Journal article
Oral nitrate therapy does not affect glucose metabolism in healthy men
DC Henstridge, SJ Duffy, MF Formosa, AA Ahimastos, BR Thompson, BA Kingwell
Clinical and Experimental Pharmacology and Physiology | Published : 2009
Abstract
Previously, we demonstrated that nitric oxide (NO) may be an important mediator of peripheral glucose disposal. The aim of the present study was to determine whether acute oral nitrate therapy improves glucose metabolism in healthy individuals. Healthy men (n = 10), aged between 19 and 46 years, participated in a randomized cross-over placebo-controlled study. During Visit 1, participants received a dose-graded intravenous infusion of sodium nitroprusside (SNP; titrated from a dose of 0.5 μg/kg per min to a maximum of 2 μg/kg per min and delivered at a rate of 2 mL/min over 30 min). On Visits 2, 3 and 4, participants received oral extended-release isosorbide mononitrate (120 mg), pentaerythr..
View full abstractGrants
Funding Acknowledgements
The authors thank Beth Johnson, Donna Vizi, Sonia Dougherty (Alfred and Baker Medical Unit, Baker IDI Heart and Diabetes Institute Melbourne) and Matthew Ellis (Allergy, Immunology and Respiratory Medicine, The Alfred Hospital and Monash University) for their expert nursing and technical assistance and Dr Robert Groves (ALPHARMA-ISIS, Langenfeld, Germany) for supplying the Pentalong medication. This project was funded by a grant from the National Health and Medical Research Council of Australia (NHMRC). BK is an NHMRC Principal Research Fellow and SD is supported by an NHMRC Program Grant.